Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Mr. Prashant Patel M.Sc., R.Ph. | Interim Co-CEO, President & Director | 1974 |
| Mr. Gerald E. Commissiong | Interim Co-Chief Executive Officer | 1982 |
| Mr. Brett Thompson | Chief Technology Officer | NA |
MEDS
DataMEDS AI, Inc.
Phone
844 203 6092
Fiscal year end
December
IPO
Feb 21, 2025
Address
3000 Bayport Drive, Tampa, FL, United States, 33607
2.24
+0.18 (+8.74%)
USD · NASDAQ
52-week range
0.82
40.85
Trading at 4% of the 52-week range
Market Cap
10.68M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
-6.88
Div. Yield
N/A
% Institutions
1.36%
% Insiders
44.47%
1 Year
-95.0%3 Year
-98.9%10 Year
-98.9%Description
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Actions
Add an action for MEDS.US, or sign in to see your action list.
People
Shareholders
Financial Highlights
Market Cap:
$10.68M
EBITDA:
$-55.39M
Book Value:
$-6.88
Earnings/Share:
$-46.68
Profit Margin:
0.00%
Operating Margin:
-412.68%
ROA (TTM):
-82.93%
ROE (TTM):
0.00%
Revenue (TTM):
$8.02M
Revenue/Share (TTM):
$3.97
Earnings Growth (YOY):
0.00%
Revenue Growth (YOY):
-77.20%
Valuation Metrics
Enterprise Value:
$40.22M
Trailing P/E:
0.00
Forward P/E:
0.00
Shares Statistics
Shares Outstanding:
5.18M
Shares Float:
1.46M
% Insiders:
44.47%
% Institutions:
1.36%
Short % Float:
11.52%
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
Line Item
Step Type
Value
Revenue
adjust
$23.34M
Cost of Goods Sold
adjust
$-32.98M
Gross Profit
subtotal
$-9.64M
SG&A
adjust
$-70.33M
Other Operating Expense
adjust
$-1.22M
Operating Income
subtotal
$-81.19M
Other / Non-Operating Items
adjust
$-20.08M
Net Income
subtotal
$-101.27M
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.